Colony Bankcorp (CBAN), a Finance stock headquartered in Fitzgerald, offers an attractive dividend yield of 2.37% with consistent dividend growth. The company has increased its dividend 5 times over the last 5 years with an average annual increase of 3.01%. With a Zacks Rank of #2 (Buy) and expected earnings growth of 11.73% for 2026, CBAN presents a compelling investment opportunity for income investors seeking both cash flow and capital appreciation.
CBAN
Colony Bankcorp Inc. · NYSE
News
5 latestColony Bankcorp (CBAN) is expected to report Q3 2026 earnings of $0.52 per share with 25.7% revenue growth, but an Earnings ESP of 0% and Zacks Rank #2 make it difficult to predict an earnings beat. Similarly, Renasant (RNST) is projected to post $0.94 EPS with a negative Earnings ESP of -1.06% and Zacks Rank #3, also making an earnings beat uncertain despite both companies' historical track records of beating estimates.
Colony Bankcorp (CBAN), a Southeast bank holding company, offers an attractive dividend yield of 2.35% with a $0.48 annualized dividend. The company has increased dividends 5 times over the last 5 years with an average annual increase of 3.01%. With a low payout ratio of 25% and expected earnings growth of 11.73% for 2026, CBAN presents a compelling investment opportunity for income investors, earning a Zacks Rank of #2 (Buy).
Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential securities law violations and breaches of fiduciary duties related to proposed mergers and acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be limiting superior competing offers. The investigations cover Beazer Homes' $33.50/share sale, Colony Bankcorp's merger, Atkore's $95.00/share sale, and Bio Green Med Solution's merger.
Mentions CBAN
Hilltop Holdings reported Q3 2026 earnings of $0.44 per share, missing the consensus estimate of $0.64 and representing a 31.25% earnings surprise. Revenue also missed expectations at $309.51 million versus the estimate.
The stock received a Zacks Rank #3 (Hold) rating, suggesting near-term performance in line with the market. The company's Banks - Southeast industry ranks in the top 27% of Zacks industries.
Headlines link to the publisher. Not investment advice.
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Community
7 daysNo sentiment yet
Board · $CBAN · 0 threads
Sign in to post on $CBAN
No threads yet
Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.